These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 14498822)

  • 1. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
    Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
    Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hexose transporter of Plasmodium falciparum is a worthy drug target.
    Joët T; Krishna S
    Acta Trop; 2004 Feb; 89(3):371-4. PubMed ID: 14744563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
    Joet T; Eckstein-Ludwig U; Morin C; Krishna S
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor.
    Joët T; Chotivanich K; Silamut K; Patel AP; Morin C; Krishna S
    Biochem J; 2004 Aug; 381(Pt 3):905-9. PubMed ID: 15107012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds.
    Ortiz D; Guiguemde WA; Johnson A; Elya C; Anderson J; Clark J; Connelly M; Yang L; Min J; Sato Y; Guy RK; Landfear SM
    PLoS One; 2015; 10(4):e0123598. PubMed ID: 25894322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality.
    Slavic K; Straschil U; Reininger L; Doerig C; Morin C; Tewari R; Krishna S
    Mol Microbiol; 2010 Mar; 75(6):1402-13. PubMed ID: 20132450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking, QM/MM, and molecular dynamics simulations of the hexose transporter from Plasmodium falciparum (PfHT).
    Fonseca AL; Nunes RR; Braga VM; Comar M; Alves RJ; Varotti Fde P; Taranto AG
    J Mol Graph Model; 2016 May; 66():174-86. PubMed ID: 27131282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters.
    Kraft TE; Heitmeier MR; Putanko M; Edwards RL; Ilagan MX; Payne MA; Autry JM; Thomas DD; Odom AR; Hruz PW
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7407-7414. PubMed ID: 27736766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering.
    Heitmeier MR; Hresko RC; Edwards RL; Prinsen MJ; Ilagan MXG; Odom John AR; Hruz PW
    PLoS One; 2019; 14(5):e0216457. PubMed ID: 31071153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT).
    Ionita M; Krishna S; Léo PM; Morin C; Patel AP
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4934-7. PubMed ID: 17587575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives.
    Fayolle M; Ionita M; Krishna S; Morin C; Patel AP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1267-71. PubMed ID: 16361099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir.
    Kraft TE; Armstrong C; Heitmeier MR; Odom AR; Hruz PW
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6203-9. PubMed ID: 26248369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes.
    Woodrow CJ; Burchmore RJ; Krishna S
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9931-6. PubMed ID: 10954735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antimalarial targets: the example of glucose transport.
    Patel AP; Staines HM; Krishna S
    Travel Med Infect Dis; 2008; 6(1-2):58-66. PubMed ID: 18342277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An expression system to screen for inhibitors of parasite glucose transporters.
    Feistel T; Hodson CA; Peyton DH; Landfear SM
    Mol Biochem Parasitol; 2008 Nov; 162(1):71-6. PubMed ID: 18708094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family.
    Joët T; Holterman L; Stedman TT; Kocken CH; Van Der Wel A; Thomas AW; Krishna S
    Biochem J; 2002 Dec; 368(Pt 3):923-9. PubMed ID: 12238947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects of green tea catechins on apicomplexan hexose transporters and mammalian orthologues.
    Slavic K; Derbyshire ET; Naftalin RJ; Krishna S; Staines HM
    Mol Biochem Parasitol; 2009 Nov; 168(1):113-6. PubMed ID: 19577593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs.
    Blume M; Hliscs M; Rodriguez-Contreras D; Sanchez M; Landfear S; Lucius R; Matuschewski K; Gupta N
    FASEB J; 2011 Apr; 25(4):1218-29. PubMed ID: 21169382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthosteric-allosteric dual inhibitors of PfHT1 as selective antimalarial agents.
    Huang J; Yuan Y; Zhao N; Pu D; Tang Q; Zhang S; Luo S; Yang X; Wang N; Xiao Y; Zhang T; Liu Z; Sakata-Kato T; Jiang X; Kato N; Yan N; Yin H
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33402433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of
    Won JY; Mazigo E; Cha SH; Han JH
    Front Cell Infect Microbiol; 2023; 13():1321240. PubMed ID: 38282613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.